MedTrace Logo

Microcurrent Stimulation for Dry Age-related Macular Degeneration

NCT04511936 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-04-08

No results posted yet for this study

Summary

Evaluate the safety and efficacy of microcurrent stimulation therapy for patients with dry age-related macular degeneration.

Conditions

Interventions

DEVICE

i-Lumen AMD

Microcurrent stimulator

DEVICE

i-Lumen AMD Sham

Sham microcurrent stimulator

Sponsors & Collaborators

  • i-Lumen Scientific, Inc.

    lead INDUSTRY

Principal Investigators

  • Timothy Jackson, MD · King's College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-01-31
Completion
2023-01-31
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04511936 on ClinicalTrials.gov